0001493152-21-012035.txt : 20210517
0001493152-21-012035.hdr.sgml : 20210517
20210517214754
ACCESSION NUMBER: 0001493152-21-012035
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210506
FILED AS OF DATE: 20210517
DATE AS OF CHANGE: 20210517
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: 22NW Fund, LP
CENTRAL INDEX KEY: 0001640809
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 21933568
BUSINESS ADDRESS:
STREET 1: 1455 NW LEARY WAY
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
BUSINESS PHONE: 206-227-3078
MAIL ADDRESS:
STREET 1: 1455 NW LEARY WAY
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: English Aron R.
CENTRAL INDEX KEY: 0001770436
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 21933569
MAIL ADDRESS:
STREET 1: 1455 NW LEARY WAY, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: 1415 RANCH ROAD 629 SOUTH, SUITE 201
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4/A
1
ownership.xml
X0306
4/A
2021-05-06
2021-05-07
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001770436
English Aron R.
C/O ANEBULO PHARMACEUTICALS, INC.
1415 RANCH ROAD 620 SOUTH, SUITE 201
LAKEWAY
TX
78734
1
0
1
1
See Explanation of Responses
0001640809
22NW Fund, LP
1455 NW LEARY WAY, SUITE 400
SEATTLE
WA
98107
0
0
1
1
See Explanation of Responses
Common Stock, par value $0.001 per share
2021-05-06
4
A
0
714250
7.00
A
3343565
I
22NW Fund, LP
Common Stock, par value $0.001 per share
4654528
I
Pharma Investors, LLC
This Form 4 is being filed to amend the prior Form 4 filed by the Reporting Persons with the U.S. Securities and Exchange Commission on May 7, 2021. The prior Form 4 is hereby corrected to state that the entity that directly holds the securities is 22NW Fund, LP, not 22NW, LP. In addition, the prior Form 4 is hereby corrected to state that the amount of securities purchased in the transaction on May 6, 2021 is 714,250, not 714,286. Accordingly, the total amount of shares owned by 22NW Fund, LP is 3,343,565. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP.
/s/ Aron R. English
2021-05-17
22NW Fund, LP; By: 22NW Fund GP, LLC: By: /s/ Aron R. English
2021-05-17